ARCHIVES

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999

In Brief: Lame Ducks continue On NCAB; Calabresi Elected To IOM; Ravikumar Moves To Yale

September 28, 1990

It is The First FDA Withdrawl Of An Accelerated Approval

November 18, 2011

Cancer Research Isn’t A Priority In Bush Budget, AACR President Says.

February 9, 2007

Longer Chemo Regimen Offers Better DFS For Premenopausal Breast Cancer

January 31, 2003

New Opportunities Still Abound In Immunology Program, Terry and other NCI Executives Say

February 27, 1976